Meeting
2016 ASCO Annual Meeting
Radiogenomics in 332 metastatic non-small cell lung cancer (NSCLC) patients.
Authors
Jordi Remon
Gustave Roussy, Université Paris-Saclay, Department of Medicine, Villejuif, France
Jordi Remon , Laura Faivre , Francesco Facchinetti , Maria Virginia Bluthgen , Jean-Pierre Pignon Sr., David Planchard , Ludovic Lacroix , Benjamin Besse , Jean-Charles Soria , Caroline Caramella
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11563)
DOI
10.1200/JCO.2016.34.15_suppl.11563
Abstract #
11563
Poster Bd #
260
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
First Author: Matthias Scheffler
Poster
2013 ASCO Annual Meeting
Differences in mutation patterns of diagnostic versus post-chemotherapy samples in patients with metastatic non-small cell lung cancer (NSCLC).
First Author: William Nassib William
Poster
2013 ASCO Annual Meeting
Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies) trial.
First Author: Giuseppe Giaccone
Poster
2020 Gastrointestinal Cancers Symposium
Molecular profiling of early-stage colorectal cancer (CRC) using targeted next generation sequencing (NGS) to predict signatures of recurrence.
First Author: Michael C. Burns